AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $172,532 | -64.1% | 25,601 | -38.4% | 0.02% | -59.1% |
| Q4 2021 | $480,000 | -31.0% | 41,582 | -76.5% | 0.04% | +33.3% |
| Q3 2021 | $696,000 | +121.7% | 176,600 | -23.6% | 0.03% | +94.1% |
| Q2 2021 | $314,000 | +5.0% | 231,100 | -5.9% | 0.02% | -19.0% |
| Q1 2021 | $299,000 | +94.2% | 245,500 | +156.8% | 0.02% | +50.0% |
| Q4 2020 | $154,000 | +94.9% | 95,600 | +218.7% | 0.01% | +7.7% |
| Q2 2020 | $79,000 | +7800.0% | 30,000 | -8.5% | 0.01% | – |
| Q3 2019 | $1,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |